SciELO - Scientific Electronic Library Online

 
vol.134 número4Hierro, oxígeno y desarrollo placentario en la génesis de la preeclampsia: Efectos de la altura en EcuadorLos Comités de de Ética Asistencial y las repercusiones jurídicas de sus informes índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

QUINONES, Luis et al. Cancer pharmacogenetics: Study of genetically determined variations on cancer susceptibility due to xenobiotic exposure. Rev. méd. Chile [online]. 2006, vol.134, n.4, pp.499-515. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872006000400015.

Pharmacogenetics is the study of genetically determined variations in the response to drugs and toxic agents, and their implications on disease. Recently, the discipline has acquired great relevancy due to the development of non-invasive molecular techniques that identify genetic variants in human beings. There is also a need to explain the individual differences in susceptibility to drug actions and disease risk. Genetic variants can modify the magnitude of a pharmacologic effect, toxicity threshold, secondary effects and drug interactions. There are approximately thirty families of drug-metabolizing enzymes with genetic variants that cause functional alterations and variations in pharmacologic activity. We summarize the general knowledge about genetic variants of biotransformation enzymes, their relationship with cancer risk and the role of ethnicity. Cancer pharmacogenetics is another promising and exciting research area that will explain why people with an almost identical group of genes, have a different susceptibility to cancer, whose etiology has genetic and environmental components

Palavras-chave : Neoplastic processes; Pharmacogenetics; Toxicogenetics; Xenobiotics.

        · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons